Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Computer modeling implicates stem cell overproduction in colon cancer initiation.

B M Boman1, J Z Fields, O Bonham-Carter

  • 1Division of Genetic and Preventive Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA. Bruce.Boman@mail.tju.edu

Cancer Research
|December 4, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Implementation of the fit body and soul, a church-based life style program for diabetes prevention in high-risk African Americans: a feasibility study.

The Diabetes educator·2010
Same author

The assessment of esophagogastroduodenoscopy tolerance a prospective study of 300 cases.

Diagnostic and therapeutic endoscopy·2008
Same author

NF-kappaB activation as a key mechanism in ethanol-induced disruption of the F-actin cytoskeleton and monolayer barrier integrity in intestinal epithelium.

Alcohol (Fayetteville, N.Y.)·2007
Same author

Symmetric division of cancer stem cells--a key mechanism in tumor growth that should be targeted in future therapeutic approaches.

Clinical pharmacology and therapeutics·2007
Same author

Regulation of oxidant-induced intestinal permeability by metalloprotease-dependent epidermal growth factor receptor signaling.

The Journal of pharmacology and experimental therapeutics·2007
Same author

The role of protein kinase C isoforms in modulating injury and repair of the intestinal barrier.

The Journal of pharmacology and experimental therapeutics·2005

Tumor initiation in the colon may stem from an overproduction of crypt stem cells. This study suggests the APC gene regulates stem cell numbers, with mutations leading to stem cell population expansion in familial adenomatous polyposis.

Area of Science:

  • Gastroenterology
  • Molecular Biology
  • Cancer Research

Background:

  • Familial adenomatous polyposis (FAP) is a premalignant condition characterized by numerous colon polyps.
  • The adenomatous polyposis coli (APC) gene is frequently mutated in FAP and sporadic colorectal cancers.
  • Understanding early events in tumorigenesis is crucial for prevention and treatment.

Purpose of the Study:

  • To investigate the hypothesis that colon tumor initiation is caused by crypt stem cell overproduction in FAP patients.
  • To determine the earliest cellular abnormalities in the colonic crypt phenotype associated with mutant APC genotype.
  • To elucidate the role of APC in regulating colonic crypt stem cell dynamics.

Main Methods:

  • Utilized a novel kinetic model of the colonic crypt to simulate cellular processes.

Related Experiment Videos

  • Analyzed the crypt labeling index as an indicator of early tissue abnormality.
  • Compared simulation outcomes with observed data from FAP patients.

    • Main Results:

    • Simulations indicated that an increased number of crypt stem cells, not altered proliferation or differentiation rates, explains the observed altered crypt labeling index.
    • The kinetic model successfully replicated the earliest tissue abnormality in FAP patients with mutant APC.
    • APC was identified as a key regulator of colonic crypt stem cell number.

    Conclusions:

    • APC mutations lead to an expansion of the colonic crypt stem cell population, initiating tumor development.
    • Crypt stem cell overproduction is a critical early event in colon tumorigenesis.
    • Targeting APC-regulated stem cell dynamics may offer therapeutic strategies for FAP and colorectal cancer.